Profile
IINN ABT BSX-PA SYK MDT BSX
Company Name Inspira Technologies Oxy B.H.N. Ltd. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Boston Scientific Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $14.76M $197.70B $175.45B $137.02B $129.65B $108.96B
Employees 0.04K 114.00K 45.00K 53.00K 95.00K 53.00K
CEO Dagi Shahar Ben-Noon Robert Ford Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha Michael F. Mahoney
Ratings
IINN ABT BSX-PA SYK MDT BSX
Quant Rating Score 1 2 3 3 1
Quant Rating Strong Sell Sell Neutral Neutral Strong Sell
Trading
IINN ABT BSX-PA SYK MDT BSX
Last Close $0.9192 $130.03 $122.18 $360.13 $96.28 $101.76
High 52 $1.54 $140.22 $122.18 $403.53 $98.43 $108.14
Low 52 $0.43 $111.1 $122.18 $337.28 $79.61 $88.03
Price vs. 52 Week High -40.31 % -7.27 % 0 % -10.76 % -2.18 % -5.9 %
Price vs. 52 Week Low 113.77 % 17.04 % 0 % 6.77 % 20.94 % 15.6 %
Total Return
IINN ABT BSX-PA SYK MDT BSX
1 Month Return -16.44 % 1.16 % 0 % -3.82 % 0.52 % 2.54 %
3 Month Return -25.87 % -0.18 % 0 % -5.68 % 3.74 % -1.25 %
6 Month Return 80.59 % -3.54 % 0 % -8.65 % 11.38 % -4.04 %
9 Month Return -0.29 % -0.12 % 0 % -6.61 % 11.86 % -3.41 %
YTD Return -9.88 % 14.96 % 0 % 0.02 % 20.53 % 13.93 %
1 Year Return -28.19 % 11.01 % 0 % -7.35 % 13.27 % 12.65 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
IINN ABT BSX-PA SYK MDT BSX
Dividend Yield Percentage (TTM) - 2.11 % - 0.95 % 2.8 % -
Dividend Paid and Capex Coverage Ration (TTM) - 1.46 % 5.44 % 2.47 % 1.29 % 5.44 %
Dividend Per Share (TTM) - 2.4 % - 3.4 % 2.83 % -
Payout Ratio (TTM) - 61.99 % - 39.56 % 75.84 % -
Growth
IINN ABT BSX-PA SYK MDT BSX
Asset Growth -13.32 % - 11.34 % 1.89 % 12.12 %
Gross Profit Growth -20.2 % 15.39 % 10.39 % 3.58 % 16.26 %
Revenue Growth - 5.67 % 11.16 % 3.62 % 17.61 %
Revenue 3 Year - 1.9 % 34.71 % 10.52 % 36.16 %
Revenue 5 Year - 29.99 % 71.94 % 20.96 % 47.52 %
Revenue 10 Year - 83.13 % 148.82 % 41.05 % 104.22 %
EBIT Growth 99.9 % 12.74 % 15.72 % 14.42 % 18.25 %
Net Income Growth 99.9 % -51.32 % 8.45 % 26.82 % 16.38 %
Net Income 3 Yeari Growth Per Share 99.98 % -5.58 % 36.22 % -3.39 % 72.31 %
Net Income 5 Yeari Growth Per Share 99.82 % 47.3 % 99.44 % 1.52 % -62.7 %
Net Income 10 Yeari Growth Per Share 97.04 % 24.34 % 122.27 % 48.51 % 1502.13 %
Operating Income Growth 100.09 % 17.92 % 11.14 % 15.77 % 20.82 %
Operating Cash Flow Growth (CFG) 3.92 % - 18.91 % 3.79 % 37.24 %
Operating 3 Year CFG 65.9 % -100 % 90.21 % 0.13 % 77.55 %
Operating 5 Year CFG -515.47 % -100 % 51.22 % 1.55 % 76.92 %
Operating 10 Year CFG -20804.63 % -100 % 452.85 % 22.45 % 143.61 %
EPS Growth 99.94 % -51.24 % 8.02 % 31.05 % 16.61 %
EPS Diluted Growth 99.94 % -51.31 % 8.25 % 30.8 % 16.52 %
Book Value Per Share -50.79 % -100 % 8.31 % -1.16 % 11.25 %
Share Holder 3 Year Equity Growth Per Share -93.91 % -100 % 33.52 % -4.58 % 26.58 %
Share Holder 5 Year Equity Growth Per Share 167.93 % -100 % 68.35 % -1.29 % 48.35 %
Share Holder 10 Year Equity Growth Per Share 1680.05 % -100 % 159.56 % -23.12 % 186.31 %
Dividend Per Share Growth - 6.54 % 5 % 1.11 % -100 %
Dividend 3 Year Growth Per Share - 25.03 % 20.89 % 10.78 % -100 %
Dividend 5 Year Growth Per Share - 63.45 % 46.18 % 29.33 % -
Dividend 10 Year Growth Per Share - 140.85 % 142.84 % 128.74 % -
Debt Growth 185.54 % - 5.23 % 13.95 % 17.44 %
Free Cash Flow Growth 4.26 % - 22.83 % -0.29 % 55.31 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2025 30 Apr 2025 31 Dec 2024
Profitability
IINN ABT BSX-PA SYK MDT BSX
Gross Profit Margin TTM 0.69 % 55.51 % 69.01 % 63.54 % 62.27 % 69.01 %
Return on Assets TTM -143.71 % 7.75 % 6.77 % 6.78 % 5.22 % 6.77 %
Return on Equity TTM -279.06 % 13.18 % 12.87 % 15.04 % 9.83 % 12.87 %
Return on Capital Employed TTM 444.96 % 11.56 % 10.62 % 14.07 % 7.63 % 10.62 %
Net Income Per EBT TTM 100 % 77.06 % 85.38 % 71.91 % 83.61 % 85.38 %
EBT Per Ebit TTM -88.43 % 105.19 % 85.24 % 80.09 % 91.74 % 85.24 %
EBIT Per Revenue TTM 2503.46 % 18.16 % 19.78 % 22.44 % 17.87 % 19.78 %
Cash Flow To Debt Ratio TTM - 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Receivables Turnover TTM - 4.26 7.1 6.22 5.44 7.1
Payables Turnover TTM 1.69 4.78 6.21 - 5.08 6.21
Inventory Turnover TTM 0.4 2.94 2.13 1.72 2.13 2.13
Fixed Asset Turnover TTM 24.14 % 385.33 % 468.06 % 647.99 % 485.18 % 468.06 %
Asset Turnover TTM 6.49 % 52.66 % 47.01 % 52.5 % 38.05 % 47.01 %
Operating Cash Flow Per Share TTM - 5.22 3.12 13.19 5.55 3.12
Free Cash Flow Per Share TTM - 3.96 2.55 11.2 4.06 2.55
Cash Per Share TTM 7.94 % 442.64 % 85.99 % 1071.9 % 649.63 % 85.99 %
Operating Cash Flow Sales Ratio TTM - 20.57 % 23.04 % 20.08 % 20.46 % 23.04 %
Free Cash Flow Operating Cash Flow Ratio TTM - 75.85 % 81.6 % 84.91 % 73.19 % 81.6 %
Cash Flow Coverage Ratios TTM - 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Price To Free Cash Flows Ratio TTM - 28.58 29.17 31.99 24.9 28.86
Price To Operating Cash Flows Ratio TTM - 21.76 23.8 27.17 18.22 23.55
Price Cash Flow Ratio TTM - 21.76 23.8 27.17 18.22 23.55
Income Statement (TTM)
IINN ABT BSX-PA SYK MDT BSX
Revenue $0B $44.33B $20.07B $25.12B $33.54B $20.07B
Gross Profit $-0B $24.61B $13.85B $15.43B $21.91B $13.85B
Gross Profit Ratio 0% 55.51% 69.01% 61.44% 65.32% 69.01%
EBITDA $-0B $11.33B $3.73B $5.69B $9.22B $3.73B
Net Income $-0B $6.52B $2.89B $3.25B $4.66B $2.89B
EPS Diluted - 3.72 1.94 8.4 3.61 1.94
Balance Sheet (MRQ)
IINN ABT BSX-PA SYK MDT BSX
Long Term Debt $0B $13.52B $9.37B $14.86B $25.64B $9.37B
Total Liabilities $0B $33.51B $17.39B $25.42B $43.42B $17.39B
Total Equity $0B $47.9B $22B $22.42B $48.26B $22B
Total Investments $0B $1.24B $0.56B $0.09B $6.75B $0.56B
Total Debt $0B $15.28B $11.15B $14.86B $28.52B $11.15B
Total Assets $0.01B $81.41B $39.4B $47.84B $91.68B $39.4B
Cash Flow Statement (TTM)
IINN ABT BSX-PA SYK MDT BSX
Net Income $-0.01B $13.4B $1.85B $3.25B $4.69B $1.85B
Inventory $-0B $-0.06B $-0.23B $0B $-0.29B $-0.23B
Dividends Paid $0B $-3.84B $0B $-1.28B $-3.59B $0B
Operating Cash Flow $-0.01B $8.56B $3.44B $5.04B $7.04B $3.44B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.76B $-1.86B $-0.79B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 112.96
ADGM Adagio Medical Holdings, Inc. 0.9905
AEMD Aethlon Medical, Inc. 2.0568
AFIB Acutus Medical, Inc. 0.0002
AHCO AdaptHealth Corp. 10.1905
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 188.715
ALUR Allurion Technologies Inc. 1.14
AMIX Autonomix Medical, Inc. Common Stock 0.3583
ANIK Anika Therapeutics, Inc. 10.165
AORT Artivion, Inc. 40.1
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 3.795
ARAY Accuray Incorporated 0.515
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.22
AVNS Avanos Medical, Inc. 14.99
AVR Anteris Technologies Global Corp. Common Stock 5.435
AXDX Accelerate Diagnostics, Inc. 0.034
Unlock